Similar articles

• Tetrahydroaminoacridine (THA) in Alzheimer's disease.

  Byrne J, Arie T. Byrne J, et al. BMJ. 1989 Apr 1;298(6677):845-6. doi: 10.1136/bmj.298.6677.845. BMJ. 1989. PMID: 2497817 Free PMC article. Review. No abstract available.
• Cholinergic side-effects of tetrahydroaminoacridine.

  Levy R. Levy R. Lancet. 1988 Dec 17;2(8625):1421. doi: 10.1016/s0140-6736(88)90608-3. Lancet. 1988. PMID: 2904542 No abstract available.
• Hepatotoxicity of tetrahydroaminoacridine.

  Ames DJ, Bhathal PS, Davies BM, Fraser JR. Ames DJ, et al. Lancet. 1988 Apr 16;1(8590):887. doi: 10.1016/s0140-6736(88)91636-4. Lancet. 1988. PMID: 2895395 No abstract available.
• Acute hepatitis after tetrahydroaminoacridine administration for Alzheimer's disease.

  Hammel P, Larrey D, Bernuau J, Kalafat M, Fréneaux E, Babany G, Degott C, Feldmann G, Pessayre D, Benhamou JP. Hammel P, et al. J Clin Gastroenterol. 1990 Jun;12(3):329-31. doi: 10.1097/00004836-199006000-00021. J Clin Gastroenterol. 1990. PMID: 2362104
• Clinical experience with and side-effects of tacrine hydrochloride in Alzheimer's disease: a pilot study.

  Forsyth DR, Surmon DJ, Morgan RA, Wilcock GK. Forsyth DR, et al. Age Ageing. 1989 Jul;18(4):223-9. doi: 10.1093/ageing/18.4.223. Age Ageing. 1989. PMID: 2683619 Review.